Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: CDP-diacylglycerol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular morphogenesis
Author: Pan, W.
Pham, V.
Stratman, A.
Castranova, D.
Kamei, M.
Kidd, K.
Lo, B.
Shaw, K.
Torres-Vazquez, J.
Mikelis, C.
Gutkind, J.
Davis, G.
Weinstein, B.
Citation: Blood, 2012; 120(2):489-498
Publisher: American Society of Hematology
Issue Date: 2012
ISSN: 0006-4971
Statement of
Weijun Pan, Van N. Pham, Amber N. Stratman, Daniel Castranova, Makoto Kamei, Kameha R. Kidd, Brigid D. Lo, Kenna M. Shaw, Jesus Torres-Vazquez, Constantinos M. Mikelis, J. Silvio Gutkind, George E. Davis and Brant M. Weinstein
Abstract: Understanding the mechanisms that regulate angiogenesis and translating these into effective therapies are of enormous scientific and clinical interests. In this report, we demonstrate the central role of CDP-diacylglycerol synthetase (CDS) in the regulation of VEGFA signaling and angiogenesis. CDS activity maintains phosphoinositide 4,5 bisphosphate (PIP2) availability through resynthesis of phosphoinositides, whereas VEGFA, mainly through phospholipase Cγ1, consumes PIP2 for signal transduction. Loss of CDS2, 1 of 2 vertebrate CDS enzymes, results in vascular-specific defects in zebrafish in vivo and failure of VEGFA-induced angiogenesis in endothelial cells in vitro. Absence of CDS2 also results in reduced arterial differentiation and reduced angiogenic signaling. CDS2 deficit-caused phenotypes can be successfully rescued by artificial elevation of PIP2 levels, and excess PIP2 or increased CDS2 activity can promote excess angiogenesis. These results suggest that availability of CDS-controlled resynthesis of phosphoinositides is essential for angiogenesis.
Keywords: Blood Vessels; Animals; Animals, Genetically Modified; Zebrafish; Humans; Diacylglycerol Cholinephosphotransferase; Phosphatidylinositols; Vascular Endothelial Growth Factor A; Zebrafish Proteins; RNA, Small Interfering; DNA, Complementary; Signal Transduction; Base Sequence; Neovascularization, Physiologic; Mutation
Rights: Copyright 2011 by The American Society of Hematology; all rights reserved.
RMID: 0030015381
DOI: 10.1182/blood-2012-02-408328
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.